Optimizing Transcranial Magnetic Stimulation for Stimulant Use Disorder

Last updated: January 21, 2025
Sponsor: University of Minnesota
Overall Status: Active - Recruiting

Phase

1

Condition

Stimulant Use Disorder

Treatment

closed-loop-trough

closed-loop-peak

Open-loop

Clinical Study ID

NCT06790576
PSYCH-2024-32713
  • Ages > 18
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

The study will recruit 50 adults with stimulant use disorder currently in treatment and abstinent for at least 2 weeks. The study will also recruit up to 10 healthy controls (adults without StUD) for initial study configuration. The study will consist of five steps that are expected to be completed over two lab visits.

Step 1: The 3T MRI scan will provide accurate prefrontal cortex anatomy for using neuronavigation for TMS. In addition, the study will use an analysis of resting fMRI connectivity to determine the location in the left DLPFC that has the maximum connectivity with the incentive-salience network.

Step 2: The study will use the data collected at the MRI to select the individual TMS location. EEG will be used to collect TEPs in response to single pulse TMS at the left DLPFC. Participants will then be randomized to one of three conditions: A) TMS unsynchronized with EEG, B) TMS synchronized with EEG theta frequency trough, and C) TMS synchronized with EEG theta frequency peak. The stimulation will be applied with an intensity of up to 120% of the resting motor threshold (which is a safe and common practice; Rossi et al., 2021). The intensity can be decreased for individual participants.

Step 3: Following randomization, the study will administer a pre-iTBS assessment.

Step 4: The study will compare brain and behavioral responses before and after the iTBS session with TMS and EEG synchronization as assigned by their randomized group.

Step 5: The study will administer a post-iTBS assessment.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Age 18 or older

  • Ability to provide consent and comply with all study procedures.

  • Meets Diagnostic and Statistical Manual of Mental Disorders criteria for StUD (Asassessed by MINI and self-report; Participants may have current comorbid drug use,but primary diagnosis must be StUD; does not apply to healthy control participants).

  • At least 2 weeks of abstinence from substance use (other than caffeine or nicotine).

  • Intention to remain in an addiction treatment program until intervention completion (does not apply to healthy control participants).

  • Confident level of English language proficiency.

Exclusion

Exclusion Criteria:

  • Any organic brain disorder (e.g. TBI, stroke).

  • Head injury resulting in skull fracture or loss of consciousness exceeding 30minutes.

  • TMS contraindication (history of seizures, metallic cranial plates/screws orimplanted device).

  • MRI contraindications (unapproved metallic implants, pacemakers or any otherimplanted electrical device, shrapnel, metallic braces, non-removable bodypiercings, pregnancy, breathing or movement disorder, claustrophobia).

  • Any psychotic disorder (Participants with other treated and stable psychiatricdisorders will be included).

  • Presence of a condition that would render study measures impossible to administer orinterpret.

  • Primary current substance use disorder diagnosis on a substance other thanstimulants or cocaine, except for caffeine or nicotine.

  • Greater than 9 months abstinence from substance use (does not apply to healthycontrol participants).

  • Pregnancy or breastfeeding.

Study Design

Total Participants: 50
Treatment Group(s): 3
Primary Treatment: closed-loop-trough
Phase: 1
Study Start date:
December 01, 2024
Estimated Completion Date:
December 01, 2026

Connect with a study center

  • University of Minnesota

    Minneapolis, Minnesota 55414
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.